ASCO 2021: Presentations about whole genome sequencing

At the congress of the American Society of Clinical Oncology (ASCO) on 4-8 June 2021 researchers Kris Samsom and Luuk Schipper of the Dutch Cancer Institute (NKI) have presented their findings on whole genome sequencing.

In the poster presentation

Whole Genome Sequencing (WGS) is feasible in routine clinical care

Kris Samsom of the Dutch Cancer Institute explains the results of their research in which they conclude that WGS is feasible in routine diagnostics.

In the poster presentation

Whole Genome Sequencing (WGS) improves sarcoma diagnosis and patient care

Luuk Schipper of the Dutch Cancer Institute explains how they came to the conclusion in their research that WGS can help improve the diagnosis and the treatment of patients with sarcomas.

More information

You read an article in the category Scientific publications. You may also be interested in Whole genome sequencing.
All news

Also read

Whole Genome Sequencing feasible in clinical practice

Whole Genome Sequencing feasible in clinical practice

20-09-2020

Interim WIDE analysis gives researchers more confidence in a positive outcome. On 21 September 2020, Dr. Kim Monkhorst, who is a …

Unraveling of genetic mechanism behind tumor formation may improve targeted treatment for cancer patients

Unraveling of genetic mechanism behind tumor formation may improve targeted treatment for cancer patients

11-08-2022

Genetic alterations in the FGFR2 gene occur in various cancer types and represent a promising target for therapies. However, clinical …

Patients can benefit from whole genome sequencing for immunotherapy

Patients can benefit from whole genome sequencing for immunotherapy

01-10-2020

Immunotherapy is an effective treatment for many people with cancer. The number of abnormalities in the DNA of the tumor in …

Would you like to be kept up to date with new developments?

Sign up for our newsletters

Want to know more about the complete DNA test?

Visit OncoAct.nl